Soiken Holdings Inc.
Soiken Holdings Inc. (2385.T) Stock Competitors & Peer Comparison
See (2385.T) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2385.T | ¥162.00 | -1.82% | 4.2B | -10.69 | -¥15.16 | +3.09% |
| 4587.T | ¥1,669.00 | -0.15% | 215.6B | 14.62 | ¥114.16 | N/A |
| 4592.T | ¥2,335.00 | -1.06% | 168.2B | -38.20 | -¥61.12 | N/A |
| 2160.T | ¥2,840.00 | +1.72% | 143.6B | -158.93 | -¥17.87 | N/A |
| 4974.T | ¥906.00 | -0.88% | 109.1B | 104.38 | ¥8.68 | +1.88% |
| 4565.T | ¥921.00 | -0.22% | 83.3B | -35.89 | -¥25.66 | N/A |
| 4593.T | ¥622.00 | -2.35% | 68.1B | -13.66 | -¥45.55 | N/A |
| 4894.T | ¥6,100.00 | -0.81% | 50.1B | -75.71 | -¥80.57 | N/A |
| 4889.T | ¥2,903.00 | -2.45% | 36.9B | 325.08 | ¥8.93 | N/A |
| 4563.T | ¥74.00 | +0.00% | 26.1B | -0.65 | -¥114.38 | N/A |
Stock Comparison
2385.T vs 4587.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4587.T has a market cap of 215.6B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4587.T trades at ¥1,669.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4587.T's P/E ratio is 14.62. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4587.T's ROE of +0.26%. Regarding short-term risk, 2385.T is more volatile compared to 4587.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4587.T's competition here
2385.T vs 4592.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4592.T has a market cap of 168.2B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4592.T trades at ¥2,335.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4592.T's P/E ratio is -38.20. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4592.T's ROE of -1.82%. Regarding short-term risk, 2385.T is less volatile compared to 4592.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4592.T's competition here
2385.T vs 2160.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 2160.T has a market cap of 143.6B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 2160.T trades at ¥2,840.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 2160.T's P/E ratio is -158.93. In terms of profitability, 2385.T's ROE is -0.04%, compared to 2160.T's ROE of -0.03%. Regarding short-term risk, 2385.T is less volatile compared to 2160.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 2160.T's competition here
2385.T vs 4974.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4974.T has a market cap of 109.1B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4974.T trades at ¥906.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4974.T's P/E ratio is 104.38. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4974.T's ROE of +0.01%. Regarding short-term risk, 2385.T is more volatile compared to 4974.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4974.T's competition here
2385.T vs 4565.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4565.T has a market cap of 83.3B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4565.T trades at ¥921.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4565.T's P/E ratio is -35.89. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4565.T's ROE of -0.03%. Regarding short-term risk, 2385.T is more volatile compared to 4565.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4565.T's competition here
2385.T vs 4593.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4593.T has a market cap of 68.1B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4593.T trades at ¥622.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4593.T's P/E ratio is -13.66. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4593.T's ROE of -1.95%. Regarding short-term risk, 2385.T is less volatile compared to 4593.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4593.T's competition here
2385.T vs 4894.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4894.T has a market cap of 50.1B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4894.T trades at ¥6,100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4894.T's P/E ratio is -75.71. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4894.T's ROE of -0.12%. Regarding short-term risk, 2385.T is less volatile compared to 4894.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4894.T's competition here
2385.T vs 4889.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4889.T has a market cap of 36.9B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4889.T trades at ¥2,903.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4889.T's P/E ratio is 325.08. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4889.T's ROE of +0.07%. Regarding short-term risk, 2385.T is less volatile compared to 4889.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4889.T's competition here
2385.T vs 4563.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4563.T has a market cap of 26.1B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4563.T trades at ¥74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4563.T's P/E ratio is -0.65. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4563.T's ROE of -2.08%. Regarding short-term risk, 2385.T is less volatile compared to 4563.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4563.T's competition here
2385.T vs 7774.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 7774.T has a market cap of 23.8B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 7774.T trades at ¥587.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 7774.T's P/E ratio is -93.32. In terms of profitability, 2385.T's ROE is -0.04%, compared to 7774.T's ROE of -0.04%. Regarding short-term risk, 2385.T is less volatile compared to 7774.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 7774.T's competition here
2385.T vs 4599.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4599.T has a market cap of 19.9B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4599.T trades at ¥321.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4599.T's P/E ratio is -9.58. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4599.T's ROE of -0.24%. Regarding short-term risk, 2385.T is less volatile compared to 4599.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4599.T's competition here
2385.T vs 4978.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4978.T has a market cap of 19.8B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4978.T trades at ¥209.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4978.T's P/E ratio is 190.00. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4978.T's ROE of +0.01%. Regarding short-term risk, 2385.T is less volatile compared to 4978.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4978.T's competition here
2385.T vs 4575.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4575.T has a market cap of 19.7B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4575.T trades at ¥1,001.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4575.T's P/E ratio is -14.04. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4575.T's ROE of -0.36%. Regarding short-term risk, 2385.T is less volatile compared to 4575.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4575.T's competition here
2385.T vs 7776.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 7776.T has a market cap of 16.5B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 7776.T trades at ¥475.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 7776.T's P/E ratio is -18.48. In terms of profitability, 2385.T's ROE is -0.04%, compared to 7776.T's ROE of -0.49%. Regarding short-term risk, 2385.T is more volatile compared to 7776.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 7776.T's competition here
2385.T vs 4588.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4588.T has a market cap of 14.7B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4588.T trades at ¥592.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4588.T's P/E ratio is -7.67. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4588.T's ROE of -1.06%. Regarding short-term risk, 2385.T is less volatile compared to 4588.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4588.T's competition here
2385.T vs 4888.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4888.T has a market cap of 14.3B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4888.T trades at ¥420.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4888.T's P/E ratio is -99.53. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4888.T's ROE of -0.05%. Regarding short-term risk, 2385.T is more volatile compared to 4888.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4888.T's competition here
2385.T vs 4880.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4880.T has a market cap of 13.5B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4880.T trades at ¥679.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4880.T's P/E ratio is -264.20. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4880.T's ROE of +0.01%. Regarding short-term risk, 2385.T is more volatile compared to 4880.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4880.T's competition here
2385.T vs 4584.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4584.T has a market cap of 12.8B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4584.T trades at ¥269.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4584.T's P/E ratio is -517.31. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4584.T's ROE of -0.02%. Regarding short-term risk, 2385.T is less volatile compared to 4584.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4584.T's competition here
2385.T vs 4579.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4579.T has a market cap of 12.6B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4579.T trades at ¥516.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4579.T's P/E ratio is -22.58. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4579.T's ROE of -0.08%. Regarding short-term risk, 2385.T is more volatile compared to 4579.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4579.T's competition here
2385.T vs 7096.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 7096.T has a market cap of 10.2B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 7096.T trades at ¥1,003.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 7096.T's P/E ratio is 26.65. In terms of profitability, 2385.T's ROE is -0.04%, compared to 7096.T's ROE of +0.14%. Regarding short-term risk, 2385.T is more volatile compared to 7096.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 7096.T's competition here
2385.T vs 2370.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 2370.T has a market cap of 10.1B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 2370.T trades at ¥38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 2370.T's P/E ratio is -7.36. In terms of profitability, 2385.T's ROE is -0.04%, compared to 2370.T's ROE of -0.27%. Regarding short-term risk, 2385.T is less volatile compared to 2370.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 2370.T's competition here
2385.T vs 4875.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4875.T has a market cap of 10B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4875.T trades at ¥204.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4875.T's P/E ratio is -5.94. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4875.T's ROE of -0.21%. Regarding short-term risk, 2385.T is less volatile compared to 4875.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4875.T's competition here
2385.T vs 4571.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4571.T has a market cap of 9.9B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4571.T trades at ¥140.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4571.T's P/E ratio is -11.80. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4571.T's ROE of -0.28%. Regarding short-term risk, 2385.T is more volatile compared to 4571.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4571.T's competition here
2385.T vs 4583.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4583.T has a market cap of 9.9B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4583.T trades at ¥145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4583.T's P/E ratio is -8.27. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4583.T's ROE of -0.66%. Regarding short-term risk, 2385.T is more volatile compared to 4583.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4583.T's competition here
2385.T vs 177A.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 177A.T has a market cap of 9B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 177A.T trades at ¥1,769.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 177A.T's P/E ratio is 11.22. In terms of profitability, 2385.T's ROE is -0.04%, compared to 177A.T's ROE of +0.15%. Regarding short-term risk, 2385.T is more volatile compared to 177A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 177A.T's competition here
2385.T vs 4564.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4564.T has a market cap of 8.8B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4564.T trades at ¥29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4564.T's P/E ratio is -9.29. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4564.T's ROE of -1.00%. Regarding short-term risk, 2385.T is less volatile compared to 4564.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4564.T's competition here
2385.T vs 4896.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4896.T has a market cap of 8.4B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4896.T trades at ¥722.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4896.T's P/E ratio is -9.90. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4896.T's ROE of -0.34%. Regarding short-term risk, 2385.T is more volatile compared to 4896.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4896.T's competition here
2385.T vs 4594.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4594.T has a market cap of 8.4B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4594.T trades at ¥72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4594.T's P/E ratio is -5.10. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4594.T's ROE of -1.16%. Regarding short-term risk, 2385.T is less volatile compared to 4594.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4594.T's competition here
2385.T vs 3750.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 3750.T has a market cap of 8.2B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 3750.T trades at ¥913.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 3750.T's P/E ratio is -3.81. In terms of profitability, 2385.T's ROE is -0.04%, compared to 3750.T's ROE of -1.14%. Regarding short-term risk, 2385.T is more volatile compared to 3750.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 3750.T's competition here
2385.T vs 4598.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4598.T has a market cap of 8B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4598.T trades at ¥697.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4598.T's P/E ratio is -3.56. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4598.T's ROE of -3.42%. Regarding short-term risk, 2385.T is less volatile compared to 4598.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4598.T's competition here
2385.T vs 2183.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 2183.T has a market cap of 7.6B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 2183.T trades at ¥337.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 2183.T's P/E ratio is -14.12. In terms of profitability, 2385.T's ROE is -0.04%, compared to 2183.T's ROE of -0.07%. Regarding short-term risk, 2385.T is more volatile compared to 2183.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 2183.T's competition here
2385.T vs 4893.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4893.T has a market cap of 7.4B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4893.T trades at ¥171.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4893.T's P/E ratio is -7.68. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4893.T's ROE of -0.18%. Regarding short-term risk, 2385.T is more volatile compared to 4893.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4893.T's competition here
2385.T vs 4891.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4891.T has a market cap of 7.3B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4891.T trades at ¥161.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4891.T's P/E ratio is -9.83. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4891.T's ROE of -0.22%. Regarding short-term risk, 2385.T is more volatile compared to 4891.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4891.T's competition here
2385.T vs 206A.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 206A.T has a market cap of 6.5B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 206A.T trades at ¥177.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 206A.T's P/E ratio is -5.06. In terms of profitability, 2385.T's ROE is -0.04%, compared to 206A.T's ROE of -0.40%. Regarding short-term risk, 2385.T is less volatile compared to 206A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 206A.T's competition here
2385.T vs 4572.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4572.T has a market cap of 5.8B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4572.T trades at ¥302.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4572.T's P/E ratio is -2.48. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4572.T's ROE of -0.88%. Regarding short-term risk, 2385.T is less volatile compared to 4572.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4572.T's competition here
2385.T vs 4576.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4576.T has a market cap of 5.1B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4576.T trades at ¥112.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4576.T's P/E ratio is -3.05. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4576.T's ROE of -1.24%. Regarding short-term risk, 2385.T is less volatile compared to 4576.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4576.T's competition here
2385.T vs 4570.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4570.T has a market cap of 4.7B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4570.T trades at ¥501.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4570.T's P/E ratio is 18.75. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4570.T's ROE of +0.18%. Regarding short-term risk, 2385.T is more volatile compared to 4570.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4570.T's competition here
2385.T vs 4881.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4881.T has a market cap of 4.5B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4881.T trades at ¥112.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4881.T's P/E ratio is -3.50. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4881.T's ROE of -0.54%. Regarding short-term risk, 2385.T is more volatile compared to 4881.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4881.T's competition here
2385.T vs 4591.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4591.T has a market cap of 4.5B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4591.T trades at ¥101.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4591.T's P/E ratio is -4.01. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4591.T's ROE of -0.32%. Regarding short-term risk, 2385.T is less volatile compared to 4591.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 4591.T's competition here
2385.T vs 4884.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4884.T has a market cap of 3.4B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4884.T trades at ¥500.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4884.T's P/E ratio is -3.76. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4884.T's ROE of -0.45%. Regarding short-term risk, 2385.T is more volatile compared to 4884.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4884.T's competition here
2385.T vs 2342.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 2342.T has a market cap of 3.4B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 2342.T trades at ¥202.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 2342.T's P/E ratio is -3.08. In terms of profitability, 2385.T's ROE is -0.04%, compared to 2342.T's ROE of -0.20%. Regarding short-term risk, 2385.T is less volatile compared to 2342.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 2342.T's competition here
2385.T vs 4596.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 4596.T has a market cap of 3.1B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 4596.T trades at ¥50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 4596.T's P/E ratio is -2.11. In terms of profitability, 2385.T's ROE is -0.04%, compared to 4596.T's ROE of -0.79%. Regarding short-term risk, 2385.T is more volatile compared to 4596.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2385.T.Check 4596.T's competition here
2385.T vs 6190.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 6190.T has a market cap of 1.7B. Regarding current trading prices, 2385.T is priced at ¥162.00, while 6190.T trades at ¥427.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 6190.T's P/E ratio is -3.85. In terms of profitability, 2385.T's ROE is -0.04%, compared to 6190.T's ROE of -0.27%. Regarding short-term risk, 2385.T is less volatile compared to 6190.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 6190.T's competition here
2385.T vs 2191.T Comparison August 2025
2385.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2385.T stands at 4.2B. In comparison, 2191.T has a market cap of 0. Regarding current trading prices, 2385.T is priced at ¥162.00, while 2191.T trades at ¥2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2385.T currently has a P/E ratio of -10.69, whereas 2191.T's P/E ratio is -0.06. In terms of profitability, 2385.T's ROE is -0.04%, compared to 2191.T's ROE of -1.44%. Regarding short-term risk, 2385.T is less volatile compared to 2191.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2385.T.Check 2191.T's competition here